Australian Clinical Labs Ltd ASX: ACL Share Price & Review

ACL Overview

ACL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Very Weak

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

About ACL

Website

N/A

Telephone

61.13.0045.3688

Address

1868-1892 Dandenong Road Clayton, Victoria (VIC) 3168

Description

Australian Clinical Labs Ltd. engages in the provision of pathology services. It operates through the Pathology segment. The Pathology segment includes pathology/clinical laboratory services provided in Australia. The company was founded in 2015 and is headquartered in Clayton, Australia.

ACL Price Chart

Key Stats

Market Cap

AU$489.48M

14.00

EV/EBITDA

2.7

Dividends Overview

DIV Yield

4.3%

Franking

100%

Ex Dividend Date (est.)

01-Sep-25

Market Data

52 weeks range

Low 2.47 - 3.86

Trade Value (12mth)

AU$719,573.00

1 week

-1.57%

1 month

-7.06%

YTD

-26.9%

1 year

-29.38%

All time high

6.39

Key Fundamentals

EPS 3 yr Growth

-80.60%

EBITDA Margin

27.00%

Operating Cashflow

$183m

Free Cash Flow Return

49.80%

ROIC

8.80%

Interest Coverage

10.80

Quick Ratio

0.50

Other Data

Shares on Issue (Fully Dilluted)

194m

HALO Sector

Healthcare

Next Company Report Date

26-Aug-26

Ex Dividend Date (est.)

01-Sep-25

Next Dividend Pay Date (est.)

23-Sep-25

Reporting Currency

AUD

Short Sell (% of issue)

5.97

ACL Announcements

Latest Announcements

Date	Announcements
15 September 25	Notification of cessation of securities - ACL × Notification of cessation of securities - ACL
10 September 25	Notification regarding unquoted securities - ACL × Notification regarding unquoted securities - ACL
10 September 25	Notification regarding unquoted securities - ACL × Notification regarding unquoted securities - ACL
03 September 25	Change in substantial holding × Change in substantial holding
02 September 25	Change in substantial holding × Change in substantial holding
29 August 25	Change in substantial holding from CBA × Change in substantial holding from CBA
29 August 25	Change in substantial holding from MUFG × Change in substantial holding from MUFG
28 August 25	Change in substantial holding × Change in substantial holding
26 August 25	Appendix 4E and Financial Report 30 June 2025 × Appendix 4E and Financial Report 30 June 2025
26 August 25	FY25 Results Announcement × FY25 Results Announcement
26 August 25	FY25 Results Presentation × FY25 Results Presentation
26 August 25	Dividend/Distribution - ACL × Dividend/Distribution - ACL
26 August 25	Change in substantial holding × Change in substantial holding
19 August 25	Investor webinar - FY25 financial results × Investor webinar - FY25 financial results
14 August 25	Change in substantial shareholding from AEF × Change in substantial shareholding from AEF
14 August 25	Change in substantial holding × Change in substantial holding
14 August 25	Ceasing to be a substantial holder from WAM/WMI/WAX × Ceasing to be a substantial holder from WAM/WMI/WAX
08 August 25	Ceasing to be a substantial holder × Ceasing to be a substantial holder
08 August 25	Ceasing to be a substantial holder from MQG × Ceasing to be a substantial holder from MQG
05 August 25	FY25 financial results and AGM × FY25 financial results and AGM
25 July 25	Change in substantial holding × Change in substantial holding
24 June 25	Becoming a substantial holder from MQG × Becoming a substantial holder from MQG
20 June 25	Appointment of new director and chair × Appointment of new director and chair
20 June 25	Initial Director's Interest Notice - S Roche × Initial Director's Interest Notice - S Roche
19 June 25	Change in substantial holding from MUFG × Change in substantial holding from MUFG
18 June 25	Change in substantial holding × Change in substantial holding

Dividends

Key Stats

Ex Dividend Date (est.)

01-Sep-25

DIV Yield

4.3%

Franking Level

100%

DPSg

4.20%

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

2.78%

Value ($M)

14

Prior Change

N/A

7 Day Change

N/A

1 Month Change

-0.40%

3 Month Change

0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ACL Shortsell

Frequently Asked Questions

What is the current share price of Australian Clinical Labs Ltd (ACL:ASX)?

The current share price of Australian Clinical Labs Ltd (ACL:ASX) is AU$2.5.

What is the 52-week high share price for Australian Clinical Labs Ltd (ACL:ASX)?

The 52-week high share price for Australian Clinical Labs Ltd (ACL:ASX) is AU$3.86.

What is the 52-week low share price for Australian Clinical Labs Ltd (ACL:ASX)?

The 52-week low share price for Australian Clinical Labs Ltd (ACL:ASX)? is AU$2.47.

What is the dividend yield for Australian Clinical Labs Ltd (ACL:ASX)?

The current TTM dividend payout for Australian Clinical Labs Ltd (ACL:ASX) is 4.30.

What was Australian Clinical Labs Ltd (ACL:ASX) last dividend payment?

The last dividend payment of Australian Clinical Labs Ltd (ACL:ASX) is AU$0.09.

What is the franking level for Australian Clinical Labs Ltd (ACL:ASX)?

Australian Clinical Labs Ltd (ACL:ASX) has a franking level of 100.0%.

In which sector is Australian Clinical Labs Ltd (ACL:ASX) classified?

Australian Clinical Labs Ltd (ACL:ASX) is classified in the Healthcare.

What is the price-to-earnings (P/E) ratio for Australian Clinical Labs Ltd (ACL:ASX)?

The current P/E ratio for Australian Clinical Labs Ltd (ACL:ASX) is 14.00.